Although no other recent epidemiological study has looked at specific effects of COX-2 inhibitors, a number of studies have investigated effects of nonspecified or combined NSAID use on breast cancer (Gill et al, 2007; Kirsh et al, 2007; Ready et al, 2008), mostly finding no association. The gene discussed is PTGS2; the disease is breast cancer.